Lung Cancer
Latest News
New Trials in Lung Cancer: Could Your Patients Benefit?
A number of lung cancer trials are recruiting for NSCLC which is locally advanced, metastatic, and with or without mutations.
Feature
Oncology Mergers Are on the Rise. How Can Independent Practices Survive?
The number of community practices acquired by hospitals nearly tripled from 2010 to 2020, according to a report from COA.
News from the FDA/CDC
FDA Approves Adagrasib for KRAS G12C–Mutated CRC
The agent is the first KRAS inhibitor approved for CRC.
Latest News
Lung Cancer Screening Can Boost Early Diagnosis, Survival
Screened patients had higher rates of diagnosis compared with unscreened patients and better overall survival rates.
Feature
Doctors Endorsing Products on X May Not Disclose Company Ties
Researchers review posts by physicians on X, looking for key words that might indicate that the posts were intended as endorsements of a product...
News from the FDA/CDC
FDA Expands Repotrectinib Label to All NTRK Gene Fusion+ Solid Tumors
The approval was based on a single-arm open-label trial in 88 adults with locally advanced or metastatic NTRK gene fusion solid tumors....
From the Journals
Are Children Born Through ART at Higher Risk for Cancer?
A slight increase in the risk for leukemia was observed in children conceived through IVF or ICSI.
Conference Coverage
‘Practice Changing’ Results for Osimertinib in Unresectable Stage III EGFR+ NSCLC
Study results, including extended median PFS of 33.5 months, are expected to lead to approval in unresectable stage III disease.
Conference Coverage
‘Groundbreaking’ Trial Shows Survival Benefits in Lung Cancer
Presentation on treatment for limited stage small cell lung cancer draws rounds of applause at the annual meeting of the American Society of...
Feature
The ASCO Annual Meeting Starts This Week
More than 7000 abstracts were submitted for this year’s meeting a new record — and over 5000 were selected for presentation.